LA Fitness vs Uncommon Therapeutics

Side-by-side comparison of AI visibility scores, market position, and capabilities

LA Fitness leads in AI visibility (94 vs 27)

LA Fitness

LeaderFitness & Wellness

Gym

Full-service fitness chain with 700 clubs in US and Canada; pools, courts, and group fitness at mid-market pricing competing between Planet Fitness and premium boutique studios.

AI VisibilityBeta
Overall Score
A94
Category Rank
#2 of 6
AI Consensus
86%
Trend
stable
Per Platform
ChatGPT
95
Perplexity
99
Gemini
94

About

LA Fitness is one of the largest fitness club chains in North America, operating approximately 700 clubs across the United States and Canada under the LA Fitness, Esporta Fitness, and City Sports Club brands. Founded in 1984 in Los Angeles and headquartered in Irvine, California, LA Fitness is privately held and targets the mainstream fitness consumer with full-service amenities — pools, basketball courts, racquetball courts, saunas, and group fitness classes — at a mid-price point that positions it between budget clubs (Planet Fitness) and premium boutique studios.

Full profile

Uncommon Therapeutics

EmergingHealthcare

General

Rare disease biotech developing polytherapy approach for Rett Syndrome (1 in 10,000 girls); founder-developed protocol validated through personal patient experience competing with Acadia Pharmaceuticals Daybue in Rett market.

AI VisibilityBeta
Overall Score
D27
Category Rank
#1121 of 1167
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
28
Perplexity
33
Gemini
36

About

Uncommon Therapeutics is a biotech company founded by Noah Auerhahn — directly inspired by his daughter's diagnosis with Rett Syndrome, a severe genetic neurological disease affecting approximately 1 in 10,000 girls — applying a polytherapy approach (combining multiple therapeutic agents targeting different disease mechanisms simultaneously) to develop treatments for serious neurological and rare diseases. After improving his daughter's quality of life through a personally developed polytherapy protocol, Auerhahn founded Uncommon Therapeutics to translate these insights into pharmaceutical products for the broader Rett Syndrome patient community.

Full profile

AI Visibility Head-to-Head

94
Overall Score
27
#2
Category Rank
#1121
86
AI Consensus
67
stable
Trend
stable
95
ChatGPT
28
99
Perplexity
33
94
Gemini
36
98
Claude
22
99
Grok
33

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.